These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1329569)
21. Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to amphicrine carcinoma. Bellur S; Van der Kwast T; Mete O Hum Pathol; 2019 Mar; 85():313-327. PubMed ID: 30481509 [TBL] [Abstract][Full Text] [Related]
22. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors. Cussenot O; Villette JM; Cochand-Priollet B; Berthon P Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663 [TBL] [Abstract][Full Text] [Related]
23. Small cell anaplastic carcinoma of the prostate: report of a case with positive urine cytology. Nguyen-Ho P; Nguyen GK; Villanueva RR Diagn Cytopathol; 1994; 10(2):159-61. PubMed ID: 8187597 [TBL] [Abstract][Full Text] [Related]
24. Paneth Cell-Like Component in Prostate Cancer - Case Report. Šojat J; Jurić B; Šoipi Š; Ulamec M; Krušlin B Acta Clin Croat; 2018 Oct; 57(Suppl 1):85-88. PubMed ID: 30457254 [TBL] [Abstract][Full Text] [Related]
26. Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases. Ro JY; Têtu B; Ayala AG; Ordóñez NG Cancer; 1987 Mar; 59(5):977-82. PubMed ID: 2434204 [TBL] [Abstract][Full Text] [Related]
27. Small cell carcinoma of the prostate. A case report. Morikawa T; Kobayashi S; Yamadori I; Okino T; Ohmori M; Kurose M Int Urol Nephrol; 1993; 25(4):379-84. PubMed ID: 8276566 [TBL] [Abstract][Full Text] [Related]
29. Small-cell neuroendocrine carcinoma of the ampullary region. A clinicopathologic, immunohistochemical, and ultrastructural study of three cases. Zamboni G; Franzin G; Bonetti F; Scarpa A; Chilosi M; Colombari R; Menestrina F; Pea M; Iacono C; Serio G Am J Surg Pathol; 1990 Aug; 14(8):703-13. PubMed ID: 1696069 [TBL] [Abstract][Full Text] [Related]
30. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
31. [Neuroendocrine carcinoma of the prostate]. Bengió V; Bengió RG Rev Fac Cien Med Univ Nac Cordoba; 2004; 61(2):74-5. PubMed ID: 16211999 [TBL] [Abstract][Full Text] [Related]
32. Eosinophilic metaplasia of the prostate: a newly described lesion distinct from other eosinophilic changes in prostatic epithelium. Cheng L; MacLennan GT; Abdul-Karim FW; Lopez-Beltran A; Montironi R Anal Quant Cytol Histol; 2008 Aug; 30(4):226-30. PubMed ID: 18773741 [TBL] [Abstract][Full Text] [Related]
33. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type]. Rimoldi DA; Antonio Costa J; Roveto S; Rivero O Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882 [TBL] [Abstract][Full Text] [Related]
34. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases. Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197 [TBL] [Abstract][Full Text] [Related]
35. Small-cell carcinoma of the endometrium: an immunohistochemical and ultrastructural analysis. Tsujioka H; Eguchi F; Emoto M; Hachisuga T; Kawarabayashi T; Shirakawa K J Obstet Gynaecol Res; 1997 Feb; 23(1):9-16. PubMed ID: 9094811 [TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine differentiation in prostatic carcinoma. di Sant'Agnese PA; de Mesy Jensen KL Hum Pathol; 1987 Aug; 18(8):849-56. PubMed ID: 3610135 [TBL] [Abstract][Full Text] [Related]
37. Oat cell carcinoma of the urinary tract. An immunohistochemical and electron microscopic study. Ordóñez NG; Khorsand J; Ayala AG; Sneige N Cancer; 1986 Dec; 58(11):2519-30. PubMed ID: 2429758 [TBL] [Abstract][Full Text] [Related]
38. Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification. Park K; Chen Z; MacDonald TY; Siddiqui J; Ye H; Erbersdobler A; Shevchuk MM; Robinson BD; Sanda MG; Chinnaiyan AM; Beltran H; Rubin MA; Mosquera JM Hum Pathol; 2014 Oct; 45(10):2136-43. PubMed ID: 25128228 [TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical study of the prostatic tissues with monoclonal antibody against gamma-seminoprotein. Analyses of benign prostatic hyperplasia, metastatic foci from adenocarcinoma of the prostate and malignant neoplasms other than adenocarcinoma of the prostate]. Fujino A; Shimura S; Murayama M; Ao T; Yokoyama E; Mashimo S; Ishibashi A; Koshiba K; Kuwao S Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):527-34. PubMed ID: 7685842 [TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. di Sant'Agnese PA Cancer; 1992 Jul; 70(1 Suppl):254-68. PubMed ID: 1350941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]